New Alcohol Screening, Brief Intervention Manual Developed

Share this content:
New Alcohol Screening, Brief Intervention Manual Developed
New Alcohol Screening, Brief Intervention Manual Developed

WEDNESDAY, July 26, 2017 (HealthDay News) -- The American Academy of Family Physicians (AAFP) has announced the development of a new alcohol screening and brief intervention manual for use in family medicine practices.

To support the efforts of family physicians to help prevent morbidity and mortality associated with risky alcohol use, the AAFP has released a manual addressing alcohol misuse. The manual was supported by funding from the U.S. Centers for Disease Control and Prevention, and created through a partnership between the AAFP and Baylor College of Medicine Practice and Implementation Center.

The manual suggests that family physicians should implement alcohol screening and brief intervention, and guides them through the process. It also addresses barriers to implementation and selection of office champions who can implement the process. Other sections of the manual address how to identify office champions; assess the office's current system for alcohol screening and intervention; define a new system for screening and intervention; and standardize the new screening system.

"It's our hope that through this manual and other training programs planned thorough partnership with the CDC and the AAFP, we can disseminate evidence-based training and knowledge and implement routine screening and brief intervention for alcohol misuse in every family practice in the United States," AAFP member Roger Zoorob, M.D., M.P.H., said in an AAFP news release.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »